AstraZeneca plc vs Elastic NV — how do they compare? AstraZeneca plc trades at $158.42 (market cap $250.84B), while Elastic NV trades at $75.22 (market cap $7.93B). The key difference: AstraZeneca plc is far larger — about 31.6× Elastic NV's market cap, and AstraZeneca plc pays a 1.97% dividend while Elastic NV pays none. Which is the better fit depends on your goals.
| AZN | ESTC | |
|---|---|---|
Market Cap | $250.84B | $7.93B |
Sector | Health | Technology |
52-Week High | $209.48 | $94.47 |
52-Week Low | $147.06 | $43.30 |
Enterprise Value | $278.12B | $7.15B |
Dividend Yield | 1.97% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Elastic N.V. (ESTC) trades at $75.11, up 7.38% in the past 24 hours, with a bullish technical signal and strong analyst consensus. Recent earnings beats, including Q1 2026 EPS of $0.61 versus $0.561 expected, highlight operational strength. The company announced AI collaborations with OpenAI and AWS security distinctions, driving positive sentiment.
Outlook remains positive due to growth prospects in AI and security, but risks include high valuation multiples and ongoing legal investigations. The stock offers upside to the consensus price target of $74.21, though investors should weigh profitability improvements against competitive pressures.
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →